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examined a total of 92 patients, of which, 30 (chronic periodontitis
[CP] group) were selected for the above analysis. The institutional
ethics committee approved this study and informed written consent
was obtained from each participant. All clinical parameter scores of
the tissue sampling areas in the CP group were signiﬁcantly higher
(b0.001) than in the control group. Complete mtDNA sequencing
revealed a total of 264 variations in the patients, including 16 novel
mutations, of which 3 were missense mutations (A4234T, A7796G,
and G8115R). We also observed signiﬁcant change in the membrane
potential and protein levels of NADH dehydrogenase, Cytochrome c
oxidase and HSP 60 in the patients.
doi:10.1016/j.bbabio.2008.05.305
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It was studied the effects of the alkylating agent 3-bromopyruvate
(3-BrPA) on ATP producing pathways of HepG2 cells. 3-BrPA decreases
HepG2 viability (10% with 10–100 μM; 25% with 300–1000 µM at
60 min; 60% with 10–100 µM; 75% with 300–1000 µM at 180 min).
150 µM 3-BrPA did not affect hexokinase-II activity, but incubation
with 150 µM for 30min decreased in 60% lactate production. Cellswere
incubated with 3-BrPA as above in glucose medium (GM-cells) or
glucose-free medium (GFM-cells) and the basal respiration was 10,5±
0,62 (GM-cells) or 15.3±0.96 (GFM-cells) nmolO2/5×106 cell×min−1. A
decrease of 22% or 50% of basal respiration by 3-BrPA was detected in
GM or GFM cells, respectively. Proton leak was increased only in GM-
cells (3.3±0.45 to 5.1±0.5). Maximum respiration was decreased only
in GFM-cells (17.3±1.1 to 9.5±1.3). 3-BrPA decreased respiratory
control ratio either in GM or GFM cells. In digitonin-permeabilized
cells, complex I supported respiration was decreased by 50% in GFM-
cells and complex-II supported respiration was inhibited by 50% in
both media. Our results suggest that glycolysis and speciﬁc sites of
mitochondria play a role in 3-BrPA-induced HepG2 death. The toxic
effects of 3BrPA depend on the oxidizable substrates supplied to cells.
doi:10.1016/j.bbabio.2008.05.306
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The aim of this study was to determine the cellular effect of
restricting glucose metabolism using 2-deoxyglucose in LN18 cells on
oxygen consumption rate (OCR) and glycolysis rate (ECAR) as well as
alterations in gene expression. The cellular OCR and ECAR were
determined using XF24 Analyzer which measures the two parameters
simultaneously in microplates. Gene expression was analyzed using
Afﬁmatrix human genome arrays. The normalized OCR of 2-deoxyglu-
cose treated LN18 cells was increased while ECAR was decreased
compared to control after 48 h treatment. This metabolic shift towards
OXPHOS was conﬁrmed by an observed increase in the sensitivity of
cellular ATP levels to oligomycin as well as increased mitochondrial
respiration capacity. Apoptosis induced by staurosporine was increased
in 2-deoxyglucose treated cells. Gene expression analysis revealed a
striking alteration in global gene expression as the result of restricted
glucose supply. OXPHOS, pentose phosphate pathway, IGF-1 signaling,
PI3K/AKT signaling, cell cycle check point, apoptosis signaling and
oxidative stress pathways were among 2710 genes showed signiﬁcantly
altered expression. Our data demonstrated that restricting glucose drove
LN-18 cells to a more oxidative state accompanied by growth suppres-
sion anddrastically alteredgeneexpression inpathways that converge at
cellular energy metabolism and cell proliferation as well as death.
doi:10.1016/j.bbabio.2008.05.307
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Hepatitis C virus (HCV) infection induces a state of oxidative stress
that ismore pronounced than that inmanyother inﬂammatory diseases.
In this study we used well-characterized cell lines inducibly expressing
the entire HCV open-reading frame to investigate the impact of viral
protein on cell bioenergetics. It was shown that HCV protein expression
has a profound effect on mitochondrial oxidative metabolism, with
speciﬁc inhibition of complex I and F1FoF1F0-ATPase activities, depres-
sion of mtΔΔ and oxidative phosphorylation coupling efﬁciency,
increased production of reactive oxygen and nitrogen species. Impor-
tantly, all these effects were causally related to mitochondrial calcium
overload, as inhibition of mitochondrial calcium uptake completely
reversed the observed bioenergetic alterations. Noteworthy, in spite of
the oxidative phosphorylation impairment, survival of HCV proteins-
expressing cells was assured by an adaptive up-regulation of glycolytic
enzymes. This was linked to normoxic stabilization of the hypoxia-
inducible factor (HIF 1α). Overall, the results presented show that
expression of HCV proteins causes deregulation of ER-mitochondrial
calcium homeostasis occurring upstream of further mitochondrial
dysfunction. The expected bioenergetic unbalance is however compen-
sated by a HIF-dependent transcriptional mechanism. These observa-
tions provide new insights into the pathogenesis of hepatitis C and may
offer new opportunities for therapeutic intervention.
doi:10.1016/j.bbabio.2008.05.308
S12.14 Novel Mt-DNA missense mutation in ND1 (A3418G→N38D)
associated with mitochondrial dysfunction in megakaryoblastic
leukaemic cells
Maria Ripolia, Claudia Piccolia, Rosella Scrimaa, Mauro Di Iannic,
Lorenzo Morettic, Massimo Carellab, Domenico Boffolia,
Antonio Tabiliod, Nazzareno Capitanioa
aDepartment of Biomedical Science, University of Foggia, Foggia, Italy
bCSS Hospital, San Giovanni Rotondo, Italy
cDepartment of Clinical and Experimental Medicine, University of
Perugia, Perugia, Italy
dDepartment of Internal Medicine and Public Health, University of
L’Aquila, L’Aquila, Italy.
E-mail: m.ripoli@unifg.it
S78 ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111
